no statement of use filed
on 20 May 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
88877227 filed on 17th Apr 2020
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT., MAILSTOP D4243
PRINCETON, NJ 08648-4000
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
N/A
N/A
No 88877227
No Service/Collective Mark
No 00138786-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th May 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
20th May 2024 | ABANDONMENT - NO USE STATEMENT FILED |
14th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Oct 2023 | SOU EXTENSION 5 GRANTED |
13th Oct 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
03rd Oct 2023 | SOU EXTENSION 5 FILED |
03rd Oct 2023 | SOU TEAS EXTENSION RECEIVED |
31st Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th Mar 2023 | SOU EXTENSION 4 GRANTED |
29th Mar 2023 | SOU EXTENSION 4 FILED |